Care Twentyone Past Earnings Performance
Past criteria checks 0/6
Care Twentyone's earnings have been declining at an average annual rate of -29.6%, while the Healthcare industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 7% per year.
Key information
-29.6%
Earnings growth rate
-29.5%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 7.0% |
| Return on equity | -2.6% |
| Net Margin | -0.3% |
| Next Earnings Update | 13 Dec 2024 |
Recent past performance updates
Recent updates
Care Twentyone Corporation's (TSE:2373) P/S Is On The Mark
Aug 07
Is Care Twentyone Corporation (TYO:2373) A Smart Pick For Income Investors?
May 08Is Care Twentyone (TYO:2373) A Risky Investment?
Mar 28If You Like EPS Growth Then Check Out Care Twentyone (TYO:2373) Before It's Too Late
Mar 15Care Twentyone Corporation's (TYO:2373) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 28Could The Care Twentyone Corporation (TYO:2373) Ownership Structure Tell Us Something Useful?
Feb 13
Is Care Twentyone Corporation (TYO:2373) A Smart Pick For Income Investors?
Jan 30Shareholders Of Care Twentyone (TYO:2373) Must Be Happy With Their 135% Total Return
Jan 15Should We Be Excited About The Trends Of Returns At Care Twentyone (TYO:2373)?
Dec 31Here's Why We Think Care Twentyone's (TYO:2373) Statutory Earnings Might Be Conservative
Dec 16A Look At The Fair Value Of Care Twentyone Corporation (TYO:2373)
Dec 02We Think Care Twentyone (TYO:2373) Can Stay On Top Of Its Debt
Nov 19Revenue & Expenses Breakdown
How Care Twentyone makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 44,340 | -117 | 8,720 | 0 |
| 30 Apr 24 | 43,197 | -480 | 8,633 | 0 |
| 31 Jan 24 | 42,072 | -39 | 8,402 | 0 |
| 31 Oct 23 | 41,098 | 6 | 8,206 | 0 |
| 31 Jul 23 | 40,239 | -9 | 8,201 | 0 |
| 30 Apr 23 | 39,505 | 131 | 7,923 | 0 |
| 31 Jan 23 | 38,842 | 233 | 7,582 | 0 |
| 31 Oct 22 | 38,398 | 630 | 7,179 | 0 |
| 31 Jul 22 | 37,887 | 909 | 7,069 | 0 |
| 30 Apr 22 | 37,432 | 981 | 6,862 | 0 |
| 31 Jan 22 | 36,995 | 959 | 6,603 | 0 |
| 31 Oct 21 | 36,361 | 937 | 6,417 | 0 |
| 31 Jul 21 | 35,826 | 761 | 6,339 | 0 |
| 30 Apr 21 | 35,117 | 802 | 6,038 | 0 |
| 31 Jan 21 | 34,501 | 721 | 5,814 | 0 |
| 31 Oct 20 | 33,984 | 711 | 5,560 | 0 |
| 31 Jul 20 | 33,300 | 559 | 5,423 | 0 |
| 30 Apr 20 | 32,575 | 453 | 5,342 | 0 |
| 31 Jan 20 | 31,795 | 407 | 5,227 | 0 |
| 31 Oct 19 | 30,964 | 300 | 5,096 | 0 |
| 31 Jul 19 | 30,250 | 582 | 4,888 | 0 |
| 30 Apr 19 | 29,598 | 509 | 4,693 | 0 |
| 31 Jan 19 | 28,914 | 322 | 4,588 | 0 |
| 31 Oct 18 | 28,120 | 210 | 4,496 | 0 |
| 31 Jul 18 | 27,354 | 111 | 4,635 | 0 |
| 30 Apr 18 | 26,673 | 222 | 4,486 | 0 |
| 31 Jan 18 | 25,974 | 281 | 4,263 | 0 |
| 31 Oct 17 | 25,225 | 733 | 4,171 | 0 |
| 31 Jul 17 | 24,470 | 362 | 4,008 | 0 |
| 30 Apr 17 | 23,688 | 256 | 4,231 | 0 |
| 31 Jan 17 | 23,120 | 203 | 4,458 | 0 |
| 31 Oct 16 | 22,568 | -230 | 4,692 | 0 |
| 31 Jul 16 | 22,038 | 120 | 4,683 | 0 |
| 30 Apr 16 | 21,632 | 187 | 4,593 | 0 |
| 31 Jan 16 | 21,179 | 272 | 4,474 | 0 |
| 31 Oct 15 | 20,707 | 337 | 4,287 | 0 |
| 31 Jul 15 | 20,188 | 357 | 4,362 | 0 |
| 30 Apr 15 | 19,598 | 305 | 4,288 | 0 |
| 31 Jan 15 | 18,959 | 275 | 4,183 | 0 |
| 31 Oct 14 | 18,355 | 287 | 4,078 | 0 |
| 31 Jul 14 | 17,684 | 254 | 4,009 | 0 |
| 30 Apr 14 | 17,031 | 280 | 3,812 | 0 |
| 31 Jan 14 | 16,446 | 288 | 3,653 | 0 |
Quality Earnings: 2373 is currently unprofitable.
Growing Profit Margin: 2373 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2373 is unprofitable, and losses have increased over the past 5 years at a rate of 29.6% per year.
Accelerating Growth: Unable to compare 2373's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2373 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.7%).
Return on Equity
High ROE: 2373 has a negative Return on Equity (-2.6%), as it is currently unprofitable.